| Robert 2006-03-31, 5:26 pm |
|
"NanoBiotech Reviews" <nanobacventures@gmail.com> wrote in message
news:1143837775.605310.120500@g10g2000cwb.googlegroups.com...
> World J Urol. 2006 Feb;24(1):51-4. Epub 2006 Jan 10. Related Articles,
> Links
>
>
> The role of nanobacteria in urologic disease.
>
> Wood HM, Shoskes DA.
>
> Glickman Urological Institute, Cleveland Clinic Foundation Cleveland,
> Mail Code: A100 OH, 9500 Euclid Avenue, Cleveland, OH 44195, USA,
> dshoskes@mac.com.
>
> Recent data proposing an extremely small, self-replicating agent termed
> "nanobacteria" has raised a great deal of controversy within the
> scientific community. Since these agents have been isolated within the
> genitourinary tract, much research has focused attention on the
> potential role these particles may play in the development of urologic
> pathology, including polycystic kidney disease, renal calculi, and
> chronic prostatitis. Recent clinical research targeting these agents
> has proven effective in treating some patients with refractory category
> III prostatitis (chronic pelvic pain syndrome). This article reviews
> the current state of nanobacteria research and explore where these
> particles may impact urologic disease.
>
> PMID: 16402263 [PubMed - in process]
>
Spam by a manufacturer
|